Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Design and Control of a 1-DOF MRI Compatible Pneumatically Actuated Robot with Long Transmission Lines.

IEEE/ASME transactions on mechatronics : a joint publication of the IEEE Industrial Electronics Society and the ASME Dynamic Systems and Control Division·2011
Same author

Effect of oxidized low-density lipoprotein concentration polarization on human smooth muscle cells' proliferation, cycle, apoptosis and oxidized low-density lipoprotein uptake.

Journal of the Royal Society, Interface·2011
Same author

Acrolein hydrogenation on Pt(211) and Au(211) surfaces: a density functional theory study.

Physical chemistry chemical physics : PCCP·2011
Same author

Anhydrous proton-conducting membrane based on poly-2-vinylpyridinium dihydrogenphosphate for electrochemical applications.

The journal of physical chemistry. B·2011
Same author

Pharmacophore identification, virtual screening and biological evaluation of prenylated flavonoids derivatives as PKB/Akt1 inhibitors.

European journal of medicinal chemistry·2011
Same author

Metabolomic study of insomnia and intervention effects of Suanzaoren decoction using ultra-performance liquid-chromatography/electrospray-ionization synapt high-definition mass spectrometry.

Journal of pharmaceutical and biomedical analysis·2011
Same journal

The rheological behavior, particle properties and supramolecular structure of low acyl gellan gum fluid gels: impact of the calcium concentration before fluid gel formation.

Carbohydrate polymers·2026
Same journal

Tuning the degree of substitution of octenyl succinic anhydride-modified highly branched cyclodextrin: Impacts on structure, physicochemical properties and emulsifying performance.

Carbohydrate polymers·2026
Same journal

Tailoring cellulose nanofibril separator networks with lignin for sustainable energy storage.

Carbohydrate polymers·2026
Same journal

Dual-functional synergistic modification of cellulose with phosphate and amidoxime for high-efficiency uranium capture in acidic wastewater.

Carbohydrate polymers·2026
Same journal

Hierarchical construction of a superhydrophobic and superior intrinsically flame-retardant phosphorylated microcrystalline cellulose bio-based composite aerogel.

Carbohydrate polymers·2026
Same journal

Structural characterization, in vitro anticoagulant, and antiplatelet activities of a Distolasterias nipon dermatan sulfate-like polymer with a distinctive sulfation pattern.

Carbohydrate polymers·2026
See all related articles

Related Experiment Video

Updated: May 14, 2026

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
07:53

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

Scutellarin-cyclodextrin conjugates: synthesis, characterization and anticancer activity.

Bo Yang1, Yu-Lin Zhao, Xia Yang

  • 1Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming 650500, PR China. yangbo6910@sina.com

Carbohydrate Polymers
|February 13, 2013
PubMed
Summary
This summary is machine-generated.

New scutellarin-cyclodextrin (SCU-CD) conjugates show enhanced aqueous solubility and stability. These improved scutellarin derivatives exhibit superior antitumor activity against human colon cancer cell lines, offering potential for chemotherapy.

More Related Videos

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

Related Experiment Videos

Last Updated: May 14, 2026

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
07:53

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

Area of Science:

  • Medicinal Chemistry
  • Nanotechnology
  • Oncology

Background:

  • Scutellarin, a natural flavonoid, possesses anticancer properties but suffers from poor aqueous solubility and stability.
  • Developing effective drug delivery systems is crucial for enhancing the therapeutic efficacy of poorly soluble compounds like scutellarin.
  • Cyclodextrins are widely used as host molecules to improve the physicochemical properties of drugs.

Purpose of the Study:

  • To synthesize and characterize novel scutellarin-cyclodextrin (SCU-CD) conjugates.
  • To evaluate the aqueous solubility, stability, and in vitro cytotoxicity of the prepared SCU-CD conjugates.
  • To assess the potential of SCU-CD conjugates as a therapeutic agent for human colon cancer.

Main Methods:

  • Synthesis of SCU-CD conjugates via covalent linkage of scutellarin to beta-cyclodextrin.
  • Structural elucidation using Nuclear Magnetic Resonance (NMR) and Mass Spectrometry (MS).
  • Physicochemical characterization by X-ray Diffraction (XRD) and Thermogravimetric Analysis (TG).
  • In vitro cytotoxicity assays on human colon cancer cell lines (HT-29, SW480, Lovo, HTC116).

Main Results:

  • SCU-CD conjugates exhibited significantly enhanced aqueous solubility compared to native scutellarin.
  • The conjugates demonstrated high stability in aqueous solutions, with minimal hydrolysis to scutellarin.
  • SCU-CD conjugates displayed improved antitumor activity against colon cancer cell lines than scutellarin.
  • XRD and TG analyses confirmed the formation and stability of the conjugates.

Conclusions:

  • SCU-CD conjugates offer a promising approach to overcome the limitations of scutellarin.
  • The enhanced solubility, stability, and potent antitumor activity make SCU-CD conjugates suitable for colon cancer chemotherapy.
  • Further in vivo studies are warranted to explore the therapeutic potential of these novel conjugates.